“Pharma, like all industries, has a responsibility to protect and enhance the environment. Our sector’s commitment takes on added significance given our role in improving people’s health.”
Scrip Asks…What Does 2023 Hold For Biopharma? Part 9: The Natural Environment
Efficiency And Collaboration Needed To Cut Sector Emissions
Improving human health is the raison d’etre of the biopharma sector. But what can the industry do to safeguard and improve the health of Planet Earth? Executives shared their thoughts with Scrip.
More from Scrip Asks
More from Scrip
• By
The Danish firm is spending nearly $580m to repurchase up to 2.2 million shares
• By
The Texas-based firm is giving up on the investigational Alzheimer’s therapy after a second Phase III failure left it with nowhere to go in the disease.
• By
Kyoto-based venture moves HQ to California to expand R&D and business outreach for its regulatory T-cell technology, as it raises around $46m in public and private funding.